DCF — ST JOSEPH MEDICAL CENTER
Enterprise Value: $-262.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-262.4M
Enterprise Value
$-82.2M
PV of Cash Flows
$-180.3M
PV of Terminal Value
$-290.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $138.6M | $-16.8M | -12.0% | $-22.7M | $-20.6M |
| Year 2 | $142.8M | $-15.9M | -11.0% | $-21.9M | $-18.1M |
| Year 3 | $147.1M | $-14.9M | -10.0% | $-21.1M | $-15.9M |
| Year 4 | $151.5M | $-14.6M | -10.0% | $-21.0M | $-14.3M |
| Year 5 | $156.0M | $-14.6M | -9.0% | $-21.2M | $-13.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-262.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$134.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12633137553082074
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5